Novabay Pharmaceuticals Inc (AMEX:NBY) traded at $0.08 at last check on Tuesday, April 30, made a downward move of -3.25% on its previous day’s price.
Looking at the stock we see that its previous close was $0.08. In terms of its 52-week price range, NBY has a high of $1.28 and a low of $0.06. The company’s stock has lost about -23.45% over that past 30 days.
Novabay Pharmaceuticals Inc has a market cap of $2.90 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.15, with the EPS growth for the year raised at -$0.27 for 2024 and $0.02 for next year. These figures represent 93.20% and 107.40% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $3.28 million, with a low of $3 million and a high of $3.56 million. The median projection represents growth squeezing down to 2.50% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $14.8 million, or 0.50% up from figures reported last year.
On the other hand, looking at the outlook for the NBY stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -7.73% off its SMA20 and -32.68% from its 50-day simple moving average. The RSI (14) is pointing at 35.28 while the volatility over the past week is 11.21% and jumps to 11.44% over the past one month. The beta value is 2.03, while the average true range (ATR) is currently pointing at 0.01.
Coming back to Novabay Pharmaceuticals Inc (AMEX:NBY), we note that the average 3-month trading volume was 2.83 million. Current shares outstanding are 36.06 million.
The insiders hold 0.04% of the company’s shares while institutions hold 3.30%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -60.64% down in year-to-date price movement.
